• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SPRINT 试验中伴有 eGFR 降低的高血压成年人中肾小管生物标志物异常的临床危险因素。

Clinical Risk Factors For Kidney Tubule Biomarker Abnormalities Among Hypertensive Adults With Reduced eGFR in the SPRINT Trial.

机构信息

Kidney Health Research Collaborative, University of California, San Francisco and San Francisco Veterans Affairs Health Care System, San Francisco, California, USA.

Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington, USA.

出版信息

Am J Hypertens. 2022 Dec 8;35(12):1006-1013. doi: 10.1093/ajh/hpac102.

DOI:10.1093/ajh/hpac102
PMID:36094158
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9729764/
Abstract

BACKGROUND

Urine biomarkers of kidney tubule health may distinguish aspects of kidney damage that cannot be captured by current glomerular measures. Associations of clinical risk factors with specific kidney tubule biomarkers have not been evaluated in detail.

METHODS

We performed a cross-sectional study in the Systolic Blood Pressure Intervention Trial among 2,436 participants with a baseline estimated glomerular filtration rate (eGFR) <60 ml/min/1.73 m2. Associations between demographic and clinical characteristics with urine biomarkers of kidney tubule health were evaluated using simultaneous multivariable linear regression of selected variables.

RESULTS

Each standard deviation higher age (9 years) was associated with 13% higher levels of chitinase-3-like protein-1 (YKL-40), indicating higher levels of tubulointerstitial inflammation and repair. Men had 31% higher levels of alpha-1 microglobulin and 16% higher levels of beta-2 microglobulin, reflecting worse tubule resorptive function. Black race was associated with significantly higher levels of neutrophil gelatinase-associated lipocalin (12%) and lower kidney injury molecule-1 (26%) and uromodulin (22%). Each standard deviation (SD) higher systolic blood pressure (SBP) (16 mmHg) was associated with 10% higher beta-2 microglobulin and 10% higher alpha-1 microglobulin, reflecting lower tubule resorptive function.

CONCLUSIONS

Clinical and demographic characteristics, such as race, sex, and elevated SBP, are associated with unique profiles of tubular damage, which could reflect under-recognized patterns of kidney tubule disease among persons with decreased eGFR.

摘要

背景

尿液肾小管健康生物标志物可以区分当前肾小球测量无法捕捉到的肾损伤方面。尚未详细评估临床危险因素与特定肾小管生物标志物之间的关联。

方法

我们在基线估算肾小球滤过率(eGFR)<60 ml/min/1.73 m2 的收缩压干预试验中进行了一项横断面研究。使用选定变量的同时多变量线性回归评估了人口统计学和临床特征与肾小管健康的尿液生物标志物之间的关联。

结果

年龄(9 岁)每增加一个标准差,壳聚糖酶-3 样蛋白-1(YKL-40)的水平就会升高 13%,表明肾小管间质炎症和修复水平较高。男性的α-1 微球蛋白水平升高 31%,β-2 微球蛋白水平升高 16%,反映出肾小管重吸收功能下降。黑种人种族与中性粒细胞明胶酶相关脂质运载蛋白(12%)水平显著升高和肾损伤分子-1(26%)和尿调蛋白(22%)水平降低有关。收缩压(SBP)每增加一个标准差(SD)(16mmHg),β-2 微球蛋白和α-1 微球蛋白的水平就会升高 10%,反映出肾小管重吸收功能下降。

结论

临床和人口统计学特征,如种族、性别和升高的 SBP,与肾小管损伤的独特特征有关,这可能反映了 eGFR 降低的人群中肾小管疾病的潜在模式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f42/9729764/2b9d5f3c6658/hpac102f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f42/9729764/2b9d5f3c6658/hpac102f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f42/9729764/2b9d5f3c6658/hpac102f0003.jpg

相似文献

1
Clinical Risk Factors For Kidney Tubule Biomarker Abnormalities Among Hypertensive Adults With Reduced eGFR in the SPRINT Trial.SPRINT 试验中伴有 eGFR 降低的高血压成年人中肾小管生物标志物异常的临床危险因素。
Am J Hypertens. 2022 Dec 8;35(12):1006-1013. doi: 10.1093/ajh/hpac102.
2
Association of Urine Biomarkers of Kidney Tubule Injury and Dysfunction With Frailty Index and Cognitive Function in Persons With CKD in SPRINT.SPRINT 研究中慢性肾脏病患者尿液肾小管损伤和功能障碍生物标志物与衰弱指数和认知功能的关系。
Am J Kidney Dis. 2021 Oct;78(4):530-540.e1. doi: 10.1053/j.ajkd.2021.01.009. Epub 2021 Feb 27.
3
Effects of Intensive Blood Pressure Lowering on Kidney Tubule Injury in CKD: A Longitudinal Subgroup Analysis in SPRINT.SPRINT 中强化降压对 CKD 肾小管损伤的影响:一项纵向亚组分析。
Am J Kidney Dis. 2019 Jan;73(1):21-30. doi: 10.1053/j.ajkd.2018.07.015. Epub 2018 Oct 2.
4
Biomarkers of Kidney Tubule Health, CKD Progression, and Acute Kidney Injury in SPRINT (Systolic Blood Pressure Intervention Trial) Participants.SPRINT(收缩压干预试验)参与者的肾脏小管健康、慢性肾脏病进展和急性肾损伤的生物标志物。
Am J Kidney Dis. 2021 Sep;78(3):361-368.e1. doi: 10.1053/j.ajkd.2021.01.021. Epub 2021 Apr 20.
5
The SPRINT trial suggests that markers of tubule cell function in the urine associate with risk of subsequent acute kidney injury while injury markers elevate after the injury.SPRINT 试验表明,尿液中的肾小管细胞功能标志物与随后发生急性肾损伤的风险相关,而损伤标志物在损伤后会升高。
Kidney Int. 2019 Aug;96(2):470-479. doi: 10.1016/j.kint.2019.03.024. Epub 2019 May 7.
6
Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD.SPRINT 试验中伴有 CKD 患者的肾小管细胞损伤和肾功能下降的尿标志物。
Clin J Am Soc Nephrol. 2020 Mar 6;15(3):349-358. doi: 10.2215/CJN.02780319. Epub 2020 Feb 28.
7
Tubular Biomarkers and Chronic Kidney Disease Progression in SPRINT Participants.SPRINT 参与者的管状生物标志物与慢性肾脏病进展。
Am J Nephrol. 2020;51(10):797-805. doi: 10.1159/000509978. Epub 2020 Sep 9.
8
Kidney tubule health, mineral metabolism and adverse events in persons with CKD in SPRINT.SPRINT 中慢性肾脏病患者的肾小管健康、矿物质代谢和不良事件。
Nephrol Dial Transplant. 2022 Aug 22;37(9):1637-1646. doi: 10.1093/ndt/gfab255.
9
Distinct Dimensions of Kidney Health and Risk of Cardiovascular Disease, Heart Failure, and Mortality.肾脏健康与心血管疾病、心力衰竭和死亡风险的不同维度。
Hypertension. 2019 Oct;74(4):872-879. doi: 10.1161/HYPERTENSIONAHA.119.13339. Epub 2019 Aug 5.
10
Urinary Biomarkers of Tubular Damage Are Associated with Mortality but Not Cardiovascular Risk among Systolic Blood Pressure Intervention Trial Participants with Chronic Kidney Disease.尿标志物与管状损伤相关,在伴有慢性肾病的收缩压干预试验参与者中与死亡率相关,但与心血管风险无关。
Am J Nephrol. 2019;49(5):346-355. doi: 10.1159/000499531. Epub 2019 Apr 2.

引用本文的文献

1
Hypertension in People Exposed to Environmental Cadmium: Roles for 20-Hydroxyeicosatetraenoic Acid in the Kidney.暴露于环境镉中的人群的高血压:20-羟基二十碳四烯酸在肾脏中的作用。
J Xenobiot. 2025 Aug 1;15(4):122. doi: 10.3390/jox15040122.
2
Urinary β-Microglobulin Predicts the Risk of Hypertension in Populations Chronically Exposed to Environmental Cadmium.尿β-微球蛋白可预测长期暴露于环境镉的人群患高血压的风险。
J Xenobiot. 2025 Mar 28;15(2):49. doi: 10.3390/jox15020049.
3
Albuminuria in People Chronically Exposed to Low-Dose Cadmium Is Linked to Rising Blood Pressure Levels.

本文引用的文献

1
Tubular Biomarkers and Chronic Kidney Disease Progression in SPRINT Participants.SPRINT 参与者的管状生物标志物与慢性肾脏病进展。
Am J Nephrol. 2020;51(10):797-805. doi: 10.1159/000509978. Epub 2020 Sep 9.
2
Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD.SPRINT 试验中伴有 CKD 患者的肾小管细胞损伤和肾功能下降的尿标志物。
Clin J Am Soc Nephrol. 2020 Mar 6;15(3):349-358. doi: 10.2215/CJN.02780319. Epub 2020 Feb 28.
3
Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
长期接触低剂量镉的人群中,蛋白尿与血压水平升高有关。
Toxics. 2025 Jan 23;13(2):81. doi: 10.3390/toxics13020081.
4
Urinary Biomarkers Of Kidney Function As Predictors Of Cardiovascular Health: A Systematic Review.作为心血管健康预测指标的肾功能尿生物标志物:一项系统评价
Curr Hypertens Rep. 2025 Feb 21;27(1):11. doi: 10.1007/s11906-025-01328-5.
5
Phenotyping Kidney Function in Young Adults With High Blood Pressure: The African-PREDICT Study.在高血压的年轻成年人中表型化肾脏功能:非洲 PREDICT 研究。
J Clin Hypertens (Greenwich). 2024 Nov;26(11):1291-1300. doi: 10.1111/jch.14911. Epub 2024 Oct 5.
6
YKL-40 as a biomarker in various inflammatory diseases: A review.YKL-40 作为多种炎症性疾病的生物标志物:综述。
Biochem Med (Zagreb). 2024 Feb 15;34(1):010502. doi: 10.11613/BM.2024.010502. Epub 2023 Dec 15.
全球、区域和国家慢性肾脏病负担,1990-2017 年:2017 年全球疾病负担研究的系统分析。
Lancet. 2020 Feb 29;395(10225):709-733. doi: 10.1016/S0140-6736(20)30045-3. Epub 2020 Feb 13.
4
Distinct Dimensions of Kidney Health and Risk of Cardiovascular Disease, Heart Failure, and Mortality.肾脏健康与心血管疾病、心力衰竭和死亡风险的不同维度。
Hypertension. 2019 Oct;74(4):872-879. doi: 10.1161/HYPERTENSIONAHA.119.13339. Epub 2019 Aug 5.
5
Markers of kidney tubule function and risk of cardiovascular disease events and mortality in the SPRINT trial.SPRINT 试验中肾小管功能标志物与心血管疾病事件及死亡率的关系。
Eur Heart J. 2019 Nov 1;40(42):3486-3493. doi: 10.1093/eurheartj/ehz392.
6
Urinary Biomarkers of Tubular Damage Are Associated with Mortality but Not Cardiovascular Risk among Systolic Blood Pressure Intervention Trial Participants with Chronic Kidney Disease.尿标志物与管状损伤相关,在伴有慢性肾病的收缩压干预试验参与者中与死亡率相关,但与心血管风险无关。
Am J Nephrol. 2019;49(5):346-355. doi: 10.1159/000499531. Epub 2019 Apr 2.
7
Kidney disease risk factors associate with urine biomarkers concentrations in HIV-positive persons; a cross-sectional study.HIV 阳性人群中,肾病风险因素与尿液生物标志物浓度相关;一项横断面研究。
BMC Nephrol. 2019 Jan 3;20(1):4. doi: 10.1186/s12882-018-1192-y.
8
Novel Urinary Biomarkers For Improved Prediction Of Progressive Egfr Loss In Early Chronic Kidney Disease Stages And In High Risk Individuals Without Chronic Kidney Disease.新型尿液生物标志物可改善早期慢性肾脏病阶段和无慢性肾脏病高危个体中进行性 EGFR 损失的预测。
Sci Rep. 2018 Oct 29;8(1):15940. doi: 10.1038/s41598-018-34386-8.
9
Kidney Damage Biomarkers and Incident Chronic Kidney Disease During Blood Pressure Reduction: A Case-Control Study.降压治疗期间的肾脏损伤生物标志物与慢性肾脏病事件:病例对照研究。
Ann Intern Med. 2018 Nov 6;169(9):610-618. doi: 10.7326/M18-1037. Epub 2018 Oct 23.
10
Effects of Intensive Blood Pressure Lowering on Kidney Tubule Injury in CKD: A Longitudinal Subgroup Analysis in SPRINT.SPRINT 中强化降压对 CKD 肾小管损伤的影响:一项纵向亚组分析。
Am J Kidney Dis. 2019 Jan;73(1):21-30. doi: 10.1053/j.ajkd.2018.07.015. Epub 2018 Oct 2.